OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer
Eleni Frangou(Nuffield Orthopaedic Centre), Sarah P. Blagden(Churchill Hospital), Rosemary Lord(Clatterbridge Cancer Centre NHS Foundation Trust), Adrian Cook(University College London), Gianfilippo Bertelli, Rosalind Glasspool(Institut Bergonié), Chrissie Butcher(University of Oxford), Michelle Ferguson(Ninewells Hospital), Sharon Love(Nuffield Orthopaedic Centre), María Cristina Quijano Martínez(Hammersmith Hospital), Shibani Nicum(London Cancer), Melanie Mackean(Edinburgh Cancer Research), Nick Hulbert-Williams(University of Chester), René L. Roux(Churchill Hospital), L. Howells, Christina Fotopoulou(Ovarian Cancer Action)
Cited by 22
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2013|1.1k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926